Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
PMID: 11035391 Hjuler, K.F., et al
Delineating the molecular mechanisms of tamoxifen's oncolytic actions in estrogen receptor-negative cancers
Documentation discipline still matters: source of API, evidence of GMP, vendor qualification, patient consent that explicitly explains the FDA approval status, and a clinical rationale tied to the individual patients condition
Phase 2 Trial The NEJM Study That Started the Conversation Study: Jastreboff AM, Kaplan LM, Fras JP, et al
Treating symptoms of male menopause, low levels of testosterone due to aging
US$ 21.82
US$ 24.55
US$ 24.63
US$ 22.72
US$ 25.19
